ARPC1B promotes gastric cancer tumorigenesis via IGF2BP3-mediated stabilization of HK2 mRNA and glycolytic reprogramming
ARPC1B drives GC progression by stabilizing HK2 mRNA through IGF2BP3 binding, thereby potentiating glycolytic reprogramming to facilitate tumor growth and metastasis. Targeting the ARPC1B-IGF2BP3-HK2 axis may represent a novel therapeutic strategy for GC.
Authors
- Junjie Ma (ORCID: https://orcid.org/0009-0000-6678-5670)
- Ting. Liu
- Longyue Wang
- Rong Yang
- Yongjing Chen
Institutions
- Shanxi Provincial Cancer Hospital (CN)
Publication Details
- Journal
- European journal of medical research
- Published
- 2026-03-09
- DOI
- https://doi.org/10.1186/s40001-026-04087-4
- Primary Topic
- Growth Hormone and Insulin-like Growth Factors
- Type
- article
- Field-Weighted Citation Impact
- 0.00